The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

There is no credible route to a zero-COVID world, UK PM Johnson says

Mon, 22nd Feb 2021 15:40

LONDON, Feb 22 (Reuters) - British Prime Minister Boris
Johnson on Monday said there was no credible route to
eliminating COVID-19 from the world and so lockdown restrictions
would be cautiously lifted in England as they cannot be
maintained indefinitely.

"There is therefore no credible route to a zero COVID
Britain or indeed a zero COVID world. And we cannot persist
indefinitely with restrictions that debilitate our economy, our
physical and mental well-being, and the life chances of our
children," Johnson told parliament as he outlined the plan to
exit restrictions.

"And that is why it is so crucial that this roadmap is
cautious but also irreversible. We’re setting out on what I hope
and believe is a one-way road to freedom."
(Reporting by Guy Faulconbridge, William James and David
Milliken, writing by Alistair Smout, editing by James Davey)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.